C. Gicquel et al., REARRANGEMENTS AT THE 11P15 LOCUS AND OVEREXPRESSION OF INSULIN-LIKE GROWTH FACTOR-II GENE IN SPORADIC ADRENOCORTICAL TUMORS, The Journal of clinical endocrinology and metabolism, 78(6), 1994, pp. 1444-1453
Little is known about the pathophysiology of sporadic adrenocortical t
umors in adults. Because loss of heterozygosity at the 11p15 locus has
been described in childhood tumors, particularly, in adrenocortical t
umors, associated with the Beckwith-Wiedemann syndrome and because ins
ulin-like growth factor-II (IGF-II) is a crucial regulator of fetal ad
renal growth, we looked for structural analysis at the 11p15 locus and
IGF-II gene expression in 23 sporadic adrenocortical adult tumors: 6
carcinomas (5 with Cushing's syndrome and 1 nonsecreting) and 17 benig
n adenomas (13 with Cushing's syndrome, 1 pure androgen secreting, and
3 nonsecreting). Twenty-one patients were informative at the 11p15 lo
cus, and six (four carcinomas and two adenomas) of them (28.5%) exhibi
ted 11p15 structural abnormalities in tumor DNA (five, an uniparental
disomy and one, a mosaicism). In a single case that could be further s
tudied, a paternal isodisomy was observed. Very high IGF-II mRNA conte
nts were detected in seven tumors (30%; 5 of the 6 carcinomas and 2 of
the 17 adenomas). They were particularly found in tumors with unipare
ntal disomy at the 11p15 locus. Overall, a strong correlation existed
between IGF-II mRNA contents and DNA demethylation at the IGF-II locus
. These data show that genetic alterations involving the 11p15 locus w
ere highly frequent in malignant tumors, but found only in rare adenom
as. These results in combination with evidence for overexpression of I
GF-II from the 11p15.5 locus suggest that abnormalities in structure a
nd/or expression of the IGF-II gene play a role as a late event of a m
ultistep process of tumorigenesis.